AMC, Netherlands, selects RayStation

The Academic Medical Center (AMC) in Amsterdam is one of the foremost research institutions in the Netherlands, as well as one of its largest hospitals. To stay at the cutting edge in radiation therapy, the center needed a new treatment planning system, with key considerations including high calculation speed, automation capabilities, adaptive planning and a user-friendly interface. RayStation was selected following an evaluation of the leading systems.

The purchase includes contouring, VMAT, IMRT, forward planning, adaptive and scripting. AMC will also become a reference center for RayStation’s Plan Explorer functionality. Plan Explorer makes it possible to automatically generate large numbers of plans for defined clinical goals and combinations of treatment techniques and machines.

Professor Coen Rasch at AMC says: “Advances in treatment have placed increasing demands on treatment planning in recent years, and our existing system has struggled to keep up. To match the pace of new developments, AMC needs a user-friendly TPS where user interactions can be scripted. Automated planning is needed for most cases, so that clinicians can focus on the more complex treatment plans, and an excellent workflow for adaptive therapy is also essential. RayStation has the capabilities we need for fast and efficient workflows and advanced techniques, and will meet our changing needs into the future.”

Johan Löf, CEO of RaySearch, says: “I am gratified to help AMC stay at the cutting edge of radiation therapy. Optimized workflows and efficient automation are key strengths of RayStation, and it is unmatched in support for adaptive therapy. I look forward to a long and successful cooperation.”

About AMC
The Academic Medical Center (AMC) is a leading Netherlands research institution and hospital. Over 7,000 people work here to provide integrated patient care, fundamental and clinical scientific research, and teaching.
AMC has 45 clinical and non-clinical departments, covering all the medical specializations recognized in the Netherlands. The hospital treats around 26,000 in-patients and 350,000 outpatients per year. A number of biotech companies (some of which are AMC spin-offs) are also located on the premises. This concentration of expertise makes the center a breeding ground for fruitful scientific collaboration.

About RayStation
RayStation integrates all RaySearch’s advanced treatment planning solutions into a flexible treatment planning system. It combines unique features such as multi-criteria optimization tools with full support for 4D adaptive radiation therapy. It also includes functionality such as RaySearch’s market-leading algorithms for IMRT and VMAT optimization and highly accurate dose engines for photon, electron, proton and carbon ion therapy. The system is built on the latest software architecture and features a graphical user interface with state-of-the-art usability.

About RaySearch
RaySearch Laboratories AB (publ) is a medical technology company that develops innovative software solutions for improved radiation therapy of cancer. RaySearch markets the RayStation treatment planning system to clinics all over the world and distributes products through licensing agreements with leading medical technology companies. The company is also developing the next-generation oncology information system, RayCare®*, which comprises a new product area for RaySearch, and which will be launched in December 2017. RaySearch’s software is used by over 2,600 clinics in more than 65 countries. The company was founded in 2000 as a spin-off from Karolinska Institutet in Stockholm and the share has been listed on NASDAQ Stockholm since November 2003.

* Subject to regulatory clearance in some markets

For further information, please contact:
Johan Löf, President and CEO, RaySearch Laboratories AB (publ)
Telephone: +46 (0)8-510 530 00

johan.lof@raysearchlabs.com

Tags:

About Us

RaySearch Laboratories is a medical technology company that develops advanced software solutions for improved radiation therapy of cancer. RaySearch markets the RayStation® treatment planning system to clinics all over the world. In addition, RaySearch’s products are distributed through licensing agreements with leading medical technology companies such as Philips, Nucletron, IBA, Varian and Brainlab. To date, 15 products have been launched via partners and RaySearch’s software is used by over 2,500 clinics in more than 65 countries. RaySearch was founded in 2000 as a spin-off from Karolinska Institute in Stockholm and the company is listed in the Small Cap segment on Nasdaq Stockholm.

Subscribe

Documents & Links